Literature DB >> 27237033

MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells.

Haibo Hu1, Zhenlei Xu2, Chang Li2, Chun Xu2, Zhe Lei3, Hong-Tao Zhang4, Jun Zhao5.   

Abstract

OBJECTIVES: MicroRNAs (miRNAs) have been proved to play important role in development of various cancers, including non-small cell lung cancer (NSCLC). Our previous studies have shown that miR-203 and miR-145 are associated with cellular invasion in NSCLC and nasopharyngeal cancer, respectively. However, the mechanistic role of miR-203 and miR-145 in TGF-β-induced epithelial-mesenchymal transition (EMT) has not yet been elucidated in human cancers, including NSCLC.
MATERIALS AND METHODS: Real-time quantitative reverse transcriptase PCR (qRT-PCR), western blot analysis, luciferase reporter gene assays, small RNA interference and transwell migration and invasion assays were carried on human NSCLC cell lines A549 and 95C. Thirty-six paired NSCLC tissues and adjacent noncancerous lung tissues were collected.
RESULTS: Both miR-145 and miR-203 can directly target the 3'-untranslated region (3'-UTR) of SMAD3, and overexpression of the two miRNAs in NSCLC cells inhibited the expression of SMAD3 mRNA and protein, whereas inhibition of endogenous miR-145 or miR-203 caused an increased expression of SMAD3. Moreover, miR-145 and/or miR-203 repressed TGF-β-induced EMT and attenuated cell migration and invasion in A549 and 95C cells. siRNA-mediated knockdown of SMAD3 copied the phenotype of miR-145 and miR-203 overexpression in A549 and 95C cells.
CONCLUSION: MiR-145 and miR-203 inhibited TGF-β-induced EMT and invasion through repression of SMAD3 in NSCLC cells. Our findings provided insights into the miRNA-based mechanism for controlling TGF-β-induced EMT of NSCLC cells and a strategy for targeted therapy of NSCLC.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Epithelial-mesenchymal transition; MiR-145; MiR-203; SMAD3

Mesh:

Substances:

Year:  2016        PMID: 27237033     DOI: 10.1016/j.lungcan.2016.04.017

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  42 in total

1.  [Research progress of exosomes in epithelial-mesenchymal transition].

Authors:  Jingyu Quan; Zibin Lu; Linzhong Yu; Chunlin Fan; Huihui Cao; Junshan Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-03-30

2.  LIN28B enhanced tumorigenesis in an autochthonous KRASG12V-driven lung carcinoma mouse model.

Authors:  Lydia Meder; Katharina König; Felix Dietlein; Iris Macheleidt; Alexandra Florin; Meryem S Ercanoglu; Ursula Rommerscheidt-Fuss; Mirjam Koker; Gisela Schön; Margarete Odenthal; Florian Klein; Reinhard Büttner; Johannes H Schulte; Lukas C Heukamp; Roland T Ullrich
Journal:  Oncogene       Date:  2018-03-05       Impact factor: 9.867

3.  MicroRNA dysregulation in the tumor microenvironment influences the phenotype of pancreatic cancer.

Authors:  Eva Karamitopoulou; Stefan Haemmig; Ulrich Baumgartner; Cornelia Schlup; Martin Wartenberg; Erik Vassella
Journal:  Mod Pathol       Date:  2017-05-26       Impact factor: 7.842

Review 4.  Response of vascular mesenchymal stem/progenitor cells to hyperlipidemia.

Authors:  Ting Chen; Yutao Wu; Wenduo Gu; Qingbo Xu
Journal:  Cell Mol Life Sci       Date:  2018-06-26       Impact factor: 9.261

Review 5.  Getting miRNA Therapeutics into the Target Cells for Neurodegenerative Diseases: A Mini-Review.

Authors:  Ming Ming Wen
Journal:  Front Mol Neurosci       Date:  2016-11-22       Impact factor: 5.639

6.  miR-203 inhibits cell proliferation, invasion, and migration of non-small-cell lung cancer by downregulating RGS17.

Authors:  Yongbin Chi; Qinqin Jin; Xinghui Liu; Limin Xu; Xiaoxue He; Yan Shen; Qiang Zhou; Jue Zhang; Mingming Jin
Journal:  Cancer Sci       Date:  2017-10-12       Impact factor: 6.716

7.  STYK1/NOK Promotes Metastasis and Epithelial-Mesenchymal Transition in Non-small Cell Lung Cancer by Suppressing FoxO1 Signaling.

Authors:  Yuanyang Lai; Fang Lin; Xuejiao Wang; Jiao Zhang; Jinghua Xia; Ying Sun; Miaomiao Wen; Xiaofei Li; Zhipei Zhang; Jinbo Zhao
Journal:  Front Cell Dev Biol       Date:  2021-07-06

8.  Estrogen receptor β promotes the vasculogenic mimicry (VM) and cell invasion via altering the lncRNA-MALAT1/miR-145-5p/NEDD9 signals in lung cancer.

Authors:  Weiwei Yu; Jie Ding; Maio He; Yuan Chen; Ronghao Wang; Zhenwei Han; Emily Z Xing; Cuntai Zhang; Shuyuan Yeh
Journal:  Oncogene       Date:  2018-09-24       Impact factor: 8.756

9.  MiR-145 inhibits the epithelial-to-mesenchymal transition via targeting ADAM19 in human glioblastoma.

Authors:  Xingqiang Wang; Enqin Wang; Jun Cao; Feng Xiong; Yonglin Yang; Haitao Liu
Journal:  Oncotarget       Date:  2017-09-30

10.  The risk of pancreatic adenocarcinoma following SARS-CoV family infection.

Authors:  Amin Ebrahimi Sadrabadi; Ahmad Bereimipour; Arsalan Jalili; Mazaher Gholipurmalekabadi; Behrouz Farhadihosseinabadi; Alexander M Seifalian
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.